IL2 and vasculitis: This clinical study confirmed the correlation of clinical improvement with boosting functional Tregs [39], and showed that low-dose IL-2 exhibited an intrinsic capacity for Treg recovery, thus improving an autoimmune condition such as HCV-induced vasculitis.